OLAGUNJU PETER (Chief Technical Officer) sold 7.6% of their position (2.62K shares) of TCR2 THERAPEUTICS INC. on the open market
Open‑market sale worth $3.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 12/7/2022ACC: 0000899243-22-037942
Officer· Chief Technical Officer
Since Jul 2021
-2.62K
Net shares
Net seller
$3.5K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
2.62K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−1.29K
Price / share
$1.37
Trade value
$1.77K
% of position
3.8%
12/5/2022
34.33K→33.04K
Common Stock
Direct
Shares
−1.33K
Price / share
$1.33
Trade value
$1.76K
% of position
4.0%
12/6/2022
33.04K→31.71K
Total
Net shares
−2.62K
Net value
-$3.53K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/5/2022 | S · Sale | −1.29K | $1.37 | $1.77K | 3.8% | 34.33K | 33.04K |
| Common Stock Direct | 12/6/2022 | S · Sale | −1.33K | $1.33 | $1.76K | 4.0% | 33.04K | 31.71K |
| Total | −2.62K | -$3.53K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned34.33K
Total
34.33K direct34.33K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 34.33K | Direct |
| Total | 34.33K | 34.33K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported